Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,843.00    -16.00 (-0.86%)
Bid:
1,841.00
Ask:
1,844.00
Spread: 3.00 (0.163%)
Market Cap: £2.06b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Directorate change

Today 07:00

RNS Number : 8440H
Derwent London PLC
11 June 2026
 

11 June 2026

 

Derwent London plc ("Derwent London" / "the Group")

Appointment of Jonathan Murphy as Chief Executive

Derwent London is pleased to announce the appointment of Jonathan Murphy as Chief Executive and an Executive Director of the Board, with effect from 1 September 2026.

Jonathan is an experienced Chief Executive with a track record of strong leadership and shareholder value creation, which is highly complementary to the skills and deep knowledge of our existing Executive team. He brings extensive listed real estate and capital markets experience, and significant operational focus. He was most recently Chief Executive Officer of Assura plc, the FTSE 250 healthcare property REIT, between February 2017 and September 2025 having previously been Finance Director since January 2013. During his tenure, Assura delivered significant growth and strategic diversification of the portfolio and capital structure before its acquisition by Primary Health Properties in 2025. Jonathan has been a director of the British Property Federation since 2019 and served on the Advisory Board of EPRA between 2018 and 2025.

Jonathan succeeds Paul Williams who announced in January 2026 his intention to retire as Chief Executive. Paul will remain as Chief Executive until 1 September 2026, at which point he will step down from the Board before leaving the business on 22 January 2027, supporting an orderly transition.

The appointment follows a thorough recruitment process led by the Board and supported by an independent executive search firm.

Mark Breuer, Chairman of Derwent London, said:

"We are delighted to appoint Jonathan as Derwent London's next Chief Executive. He brings a strong combination of listed real estate leadership, operational discipline and capital markets expertise, with a proven track record of responsible value creation. Alongside our talented Executive team, he will provide strong leadership as we continue to recycle capital through disposals and position the business to deliver earnings growth and long-term returns for shareholders."

Jonathan Murphy said:

"I am excited to be joining Derwent London as Chief Executive. The Group has a distinctive culture and brand, impressive property expertise, and a well-positioned portfolio which presents many opportunities to drive returns. I look forward to working with the Board and the wider team to build on these strengths and further optimise the business at this important time for the Group."

Other matters

Jonathan's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders at the AGM on 15 May 2026. He will receive an annual salary of £650,000, a pension allowance of 15% of salary in line with the contribution available to the majority of the wider workforce, and will participate in the Group's annual bonus and long-term incentive plan. Full details will be disclosed in the 2026 Directors' Remuneration Report. 

This announcement has been made pursuant to UK Listing Rule 6.4.6R and 6.4.7R. There is no further information relating to Jonathan Murphy which is to be disclosed under Listing Rule 6.4.8R.

For further information, please contact:

Derwent London

Tel: +44 (0)20 3478 4217

Mark Breuer, Chairman

David Lawler, Company Secretary

Robert Duncan, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

Simon Sporborg

Nina Coad

Notes to editors

Derwent London plc

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.1 billion as at 31 December 2025, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, with its updated pathway published in 2025. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 200 community projects in central London.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDLSBBDGLG
Date   Source Headline
11th Jun 20267:00 amRNSDirectorate change
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.